Genotypic drug-resistance prediction for MTBC is rapidly becoming more favoured than phenotypic drug-susceptibility testing due to its comparative speed and reliability 1 and has been endorsed by the ...
STRI copy 39088014660302 purchased with funds from the S. Dillon Ripley Endowment. SERC copy 39088016914160 purchased with funds from the S. Dillon Ripley Endowment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results